Corcept Therapeutics is trading $83.70, up 4.03%, with biotech-sector strength providing the immediate backdrop.
- As of 1:45 p.m. ET on November 3, the XBI was up 2.13% during the regular session amid sector rotation.
- No company-specific announcement explaining the intraday gain was found.
- Corcept is scheduled to report third-quarter results after the market close and host a conference call at 5:00 p.m. ET; results had not been released at the time of this alert.